Skip to main content
Equibles

MILLENNIUM MANAGEMENT LLC

Position in VKTX — Viking Therapeutics, Inc.

CIK 1273087 NEW YORK, NY
Back to VKTX Full portfolio

Position in VKTX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$8,152,083
+$5,133,604 QoQ
Shares Held
250,525
+192.0% QoQ
Ownership
0.216%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in VKTX Over Time

Shares Held

Position Value (USD)

Derivatives in VKTX

reported options exposure · as of Mar 31, 2026
CallValue
$2,463,278
CallShares
75,700
PutValue
$1,627,000
PutShares
50,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

MILLENNIUM MANAGEMENT LLC holds $4,570,822,033 across 342 Biotechnology names. VKTX ranks #128 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 JAZZ
Jazz Pharmaceuticals plc
 1,262,511 $238,677,704
2 INSM
INSMED Inc
 1,157,786 $189,321,166
3 BMRN
Biomarin Pharmaceutical Inc
 3,010,308 $170,052,298
4 TERN
Terns Pharmaceuticals, Inc.
 3,011,558 $158,769,337
5 ALNY
Alnylam Pharmaceuticals, Inc.
 447,887 $148,192,371
6 FOLD
AMICUS THERAPEUTICS, INC.
 7,908,459 $114,356,317
7 ARDX
Ardelyx, Inc.
 17,842,370 $106,875,796
8 BLTE
Belite Bio, Inc
 570,088 $90,894,830

All Filings in VKTX

Export CSV
45 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $8,152,083 250,525
2026-03-31 $2,463,278 75,700
2026-03-31 $1,627,000 50,000
2025-12-31 $5,277,000 150,000
2025-12-31 $3,018,479 85,801
2025-09-30 $11,239,824 427,695
2025-09-30 $5,376,888 204,600
2025-06-30 $3,927,300 148,200
2025-06-30 $530,000 20,000
2025-06-30 $24,961,330 941,937
2025-03-31 $6,101,376 252,645
2025-03-31 $4,950,750 205,000
2024-12-31 $6,575,216 163,400
2024-12-31 $382,280 9,500
2024-12-31 $4,133,935 102,732
2024-09-30 $525,473 8,300
2024-09-30 $10,909,705 172,322
2024-09-30 $633,100 10,000
2024-06-30 $614,916 11,600
2024-06-30 $3,795,516 71,600
2024-06-30 $38,326,972 723,014
2024-03-31 $32,561,298 397,089
2024-03-31 $836,400 10,200
2023-12-31 $7,497,150 402,856
2023-09-30 $17,631,122 1,592,694
2023-09-30 $1,266,408 114,400
2023-09-30 $495,936 44,800
2023-06-30 $29,552,775 1,823,120
2023-06-30 $697,030 43,000
2023-06-30 $1,993,830 123,000
2023-03-31 $63,902,633 3,837,996
2023-03-31 $3,846,150 231,000
2023-03-31 $5,582,745 335,300
2022-12-31 $4,198,980 446,700
2022-12-31 $376,000 40,000
2022-12-31 $41,195,500 4,382,500
2022-09-30 $8,440,244 3,103,031
2022-06-30 $3,799,644 1,314,756
2022-03-31 $4,505,658 1,501,886
2021-12-31 $945,990 205,650
2021-09-30 $371,826 59,208
2021-06-30 $285,579 47,676
2020-09-30 $204,229 35,091
2020-06-30 $2,889,003 400,694
2020-03-31 $221,115 47,247

Report a Problem

Category
Description
Email (optional, for follow-up)